Medical Microbiology articles for Canada

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 61

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.57
Transparent UV-Curable Self-Sanitizing Coatings Applicable to Diverse Surfaces and High-Touch Screens to Mitigate Deadly Pathogen Transmission 0.57
1 0.04
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence 0.04
1 0.08
Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis 0.08
2 0.05
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections 0.03
Genomic atlas of Bifidobacterium infantis and B. longum informs infant probiotic design 0.02
7 3.87
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years 0.10
Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalisation and Emergency Department Visits Associated with Respiratory Syncytial Virus in Older Adults: A Meta-Analysis 0.83
Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy 0.92
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV 0.10
Real-World Effectiveness of Nirmatrelvir-Ritonavir in Preventing Coronavirus Disease 2019–Associated Hospitalization: A Population-Based Cohort Study in the Province of Québec, Canada 1.00
HBV Care Cascade in Rwanda: A Population-based Study From 2016–2023 0.82
Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and Canada 0.10
3 0.27
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study 0.07
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) 0.17
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.03
1 1.00
Nirsevimab Against Hospitalizations and Emergency Department Visits for Lower Respiratory Tract Infection in Infants 1.00
4 2.81
EsxA is required for antibacterial toxin export by the type VIIb secretion system 1.00
Structural and mechanistic basis of ubiquitous bacterial kinase signaling identifies PorX as a noncanonical substrate in Porphyromonas gingivalis 0.69
The biosynthesis of N-acylated tryptazolone in Mycobacterium tuberculosis and related bacteria 1.00
A Variant of the MenB Strain of Synechocystis sp. PCC 6803 Disrupts a Stress Response Pathway Allowing DMPBQ to Occupy the A1 Sites of Photosystem I 0.11
1 0.16
P selectin promotes SARS-CoV-2 interactions with platelets and the endothelium 0.16
3 1.20
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort 0.12
A single-cell atlas of the woodchuck liver reveals cellular programs conserved in human HBV infection 1.00
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program 0.09
6 4.23
Detection of Marburg Virus Antibodies 25 Years After Outbreak in Watsa, Democratic Republic of the Congo 0.06
Immunogenicity of two versus three doses of hepatitis B vaccine when administered to children aged 2-18 months: a randomized clinical trial. 1.00
A rapid assay for HCV RNA detection using RT-LAMP coupled CRISPR-Cas12b based strategy 1.00
Serum markers of fibroinflammatory activity PRO-C3 and CPa9-HNE are associated with liver-related outcomes in patients with Chronic Hepatitis C 0.17
Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada 1.00
Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019 1.00
1 1.00
Respiratory Syncytial Virus (RSV)‐Related Hospitalization and Increased Rate of Cardiovascular Events in Older Adults 1.00
13 6.66
Nationwide spread of multidrug resistant Klebsiella pneumoniae across US communities 0.04
OC43 clinical isolate spike proteins have distinct carbohydrate-binding properties 0.87
Biophysical characterization of Eag chaperones suggests the mechanism of effector transmembrane domain release 1.00
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.04
Staphylococcus aureus induces Gasdermin A-dependent keratinocyte pyroptosis 0.29
The assembly of a hybrid type IV secretion system by a Crohn’s disease-associated strain 0.77
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant infection in vivo 0.13
Effect of intrapartum azithromycin on early childhood gut mycobiota development: post hoc analysis of a double-blind randomized trial 0.08
Coniontins, lipopetaibiotics active against identified from a microbial natural product fractionation library 1.00
The structure of the Tad pilus alignment complex reveals a periplasmic conduit for pilus extension 0.33
Disruption of the ATP-dependent unfoldase ClpX reverses antifungal resistance in Cryptococcus neoformans 0.85
Colistin enhances caspofungin antifungal efficacy against by modulating calcium homeostasis and stress responses 0.31
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids 0.95
1 0.13
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans 0.13
1 0.05
Heterologous two-dose Ebola vaccine regimen in pregnant women in Rwanda: a randomized controlled phase 3 trial 0.05
1 0.88
Expansion of the functional genomics GRACE library reveals genes relevant for temperature-dependent fitness in Candida albicans. 0.88
2 1.17
Twitching motility suppressors reveal a role for FimX in type IV pilus extension dynamics. 0.67
Polymerization and flanking domains of the bactofilin BacA collectively regulate stalk formation in Asticcacaulis biprosthecum 0.50
1 0.02
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials 0.02
1 0.28
Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence 0.28
1 0.04
Pre-European contact leprosy in the Americas and its current persistence 0.04
1 0.94
Human retinoic acid–inducible gene I (RIG-I) deficiency associated with susceptibility to classic Kaposi sarcoma 0.94
2 0.06
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi 0.01
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study 0.05
2 0.13
WHO estimates of the global, regional, and national foodborne burdens of 14 invasive parasitic diseases, 2000–21: an updated data synthesis 0.10
Treatment of chronic hepatitis B in Ethiopia: 1-year results from a real-life, multicentre, prospective cohort study 0.03
4 0.38
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.02
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients 0.29
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.04
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.03

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.